Statins and pancreatic cancer: Are all statins the same?

American Journal of Gastroenterology

Volumn 104, Issue 2, 2009, Pages 525-

  Vítek, Libor ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN;

CANCER RISK; DRUG EFFICACY; HUMAN; LETTER; LIPOPHILICITY; PANCREAS CANCER; PRIORITY JOURNAL;

EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PANCREATIC NEOPLASMS;

EID: 59749096717     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.103     Document Type: Letter

References (3)

1. Bonovas S, Filioussi K, Sitaras NM.Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies. Am J Gastroenterol 2008;103:1-6.
2. Moorman PG, Hamilton RJ.Statins and the cancer risk. What do we know and where do we go from here? Epidemiology 2007;18:194-6.
3. Gbelcová H, Leníček M, Zelenka J et al. Differences in antitumor effects of various statins on human pancreatic cancer. Int J Cancer 2008;122:1214-21.